Terry Myerson
Terry Myerson previously served as CEO and co-founder at Truveta and as Executive Vice President at Microsoft. He founded Intersé Corporation, which was acquired, and co-founded Truveta, which has grown into a healthcare data and AI company. His expertise includes building products, teams, and companies.
Temporal rises to No. 1 on GeekWire 200 after $550M raise at $12.55B valuation as AI and hardware firms climb
Temporal is now the No. 1 company on the GeekWire 200 after a $550 million raise valuing it at $12.55 billion and surpassing $250 million in annualized revenue; the Fall 2026 ranking highlights growth in AI software and advanced machinery for space, energy and defense across the Pacific Northwest.
Truveta CEO Terry Myerson to Retire End of September; Co-founders Ryan Ahern and Jay Nanduri Named Interim Co-CEOs
Terry Myerson will retire as Truveta CEO at the end of September after leading the Bellevue-based health data company since its 2020 launch, and two co-founders will serve as interim co-CEOs while the board searches for a permanent successor. Truveta, valued at over $1 billion after a $320 million funding round in January 2025, stores and categorizes electronic health records for research and counts 30 health system members.
Ryan Ahern thanks Terry Myerson as Myerson retires after six years leading Truveta
Ryan Ahern reflects on Terry Myerson’s retirement, praising Myerson’s vision in founding Truveta and crediting his leadership for the organization’s six years of progress in accelerating healthcare research and improving patient care.
Truveta CEO Terry Myerson to Retire in September; Co-founders Jay Nanduri and Ryan Ahern Named Interim Co-CEOs
Terry Myerson, co-founder and CEO of Truveta, will retire at the end of September and become an advisor, while co-founders Jay Nanduri and Ryan Ahern will serve as interim co-CEOs as the board searches for a permanent replacement; Truveta has grown to about 500 employees, a valuation above $1 billion, and aggregates de-identified records from 30 U.S. health systems for customers including drug makers and researchers.
Truveta CEO and co-founder Terry Myerson to retire after 6+ years; announcement dated Sept. 15, 2026
Truveta CEO and co-founder Terry Myerson announced his retirement effective after more than six years leading the company and over 30 years in technology, data, and healthcare; he helped grow Truveta into a partner to 100+ organizations using real-world clinical data from 140 million patient journeys. The announcement was made in a Sept. 15, 2026 Globe Newswire release from Bellevue, Wash.
Starcloud Becomes Fastest Y Combinator Unicorn at $1.1B as Fusion Leader Helion Tops GeekWire 200 with $15.5B Valuation
The latest GeekWire 200 highlights a shift in the Pacific Northwest startup scene toward physical products like rockets, fusion reactors, and space-based data centers, with Starcloud becoming the fastest Y Combinator unicorn valued at $1.1 billion. Helion maintains the top spot with a $15.5 billion valuation, while notable companies like Stoke Space, Overland AI, and new unicorn XBOW also make significant moves.
Terry Myerson - CEO and Co-Founder at Truveta
Terry Myerson is CEO and co-founder of Truveta, a leader in EHR data and analytics, led by a growing health system collective that together provide more than 18% of all daily clinical care in the US. Truveta is trusted by more than 50 leading healthcare and life science customers to study safety and effectiveness, improve patient care, and train medical AI. Across these leading organizations, Truveta connects data, people, and ideas to pursue the mission of Saving Lives with Data. Terry previously enjoyed a 21-year career at Microsoft, leading the development of Windows, Xbox, and the early days of Office…
Seattle's Truveta Raises $320M to Launch Largest Genomic Database with 10 Million Exomes Sequenced
Seattle-based health data company Truveta secured $320 million from 17 health systems, Illumina, and Regeneron to launch the Truveta Genome Project, aiming to create the largest and most diverse genomic and phenotypic dataset ever assembled, greatly surpassing previous efforts. The project will sequence exomes of 10 million volunteers using biospecimens linked to anonymized medical records to advance genetic research and healthcare insights.
GeekWire returns in person for 2022 Awards at Showbox SoDo, honoring 60+ finalists across 15 categories with 16,000+ votes
GeekWire held its first in-person GeekWire Awards in three years at Showbox SoDo in Seattle, honoring 60+ finalists across 15 categories with over 16,000 community votes and appearances by local tech leaders and entertainers.
Five Finalists for 2022 GeekWire Health Innovation of the Year Include A-Alpha Bio and UW Institute for Protein Design
The 2022 GeekWire Health Innovation of the Year finalists include A-Alpha Bio, Parse Biosciences, Tasso, Truveta, and the University of Washington’s Institute for Protein Design, highlighting advances in computational health approaches. Winners will be announced on May 12 at the GeekWire Awards, with community voting open until April 22.
Andreessen Horowitz, Madrona and other tech VCs ramp up bets on AI-driven biotech startups as founders from software enter life sciences
Tech venture capital firms like Andreessen Horowitz and Seattle’s Madrona Venture Group are increasingly investing in life-science startups that use AI, machine learning and data science to speed drug discovery and development. Investors are following founders who transitioned from software to biotech—such as Sujal Patel of Nautilus and Terry Myerson of Truveta—seeing reduced perceived risk and new opportunity at this intersection.
Truveta launches early health-data platform, signs Ochsner, Saint Luke’s and UnityPoint; funding nears $200M
Seattle startup Truveta launched an early version of its health data platform, added three provider partners and now says it has raised nearly $200 million in funding to aggregate clinical data across systems.
Microsoft invests in Seattle startup Truveta and partners to run health-data analyses on Azure
Seattle health-data startup Truveta will use Microsoft Azure under a new partnership and received an undisclosed Microsoft investment; the company aggregates de-identified data from 17 health systems representing about 15% of U.S. patients. Truveta, led by former Microsoft exec Terry Myerson, previously raised $95 million from healthcare partners including Providence and says the data will support research and care decisions, not targeted patient advertising.
Former Tech Leaders Join Biotech: Isilon Founder Sujal Patel, Ex-Microsoft Terry Myerson and Others Lead AI-Driven Life Sciences Startups
Several former software and tech executives are moving into biotech and life sciences startups, bringing AI, machine learning, and tech-style business models to companies that analyze proteins, microbes, and medical records. Their tech backgrounds are reshaping product development and funding approaches at firms such as Nautilus Biotechnology, Truveta, insitro and Viome.
Truveta raises $95M from 17 partner systems, gains access to >15% of U.S. patient records across 40 states
Seattle health-data startup Truveta raised $95 million in Series A funding from its 17 partner healthcare systems and added three new partners, giving it access to records covering more than 15% of U.S. patient care across 40 states. CEO Terry Myerson says the pooled data and insurance claims will let researchers and life sciences companies link treatments to outcomes to improve patient care and safety research.
Seattle Foundation CEO Tony Mestres to become president of health data startup Truveta in May
Tony Mestres will leave his role as president and CEO of the Seattle Foundation in May to become president of Truveta, a health data startup led by former Microsoft Windows chief Terry Myerson. Truveta, founded by 14 U.S. health systems to pool data and apply AI for medical research and equity analysis, appoints Mestres after his seven-year tenure at the Seattle Foundation.
Fourteen U.S. health systems form Seattle startup Truveta to pool de-identified data for AI-driven research
Fourteen U.S. health systems representing tens of millions of patients across 40 states formed Seattle startup Truveta to pool de-identified patient data and use AI to search for medical breakthroughs and detect healthcare inequities. Led by CEO Terry Myerson and governed by the participating systems, Truveta has 53 employees and says it will enable more statistically representative research populations while protecting patient privacy.
Terry Myerson launches Seattle health-data startup Truveta to develop patient-care innovations, pledges strict privacy
Terry Myerson, former head of Microsoft's Windows and Devices Group, launched Seattle-area health-data startup Truveta to use patient data for developing treatments and improving care while emphasizing strong privacy protections. The company has hired nearly 20 people, plans to grow, declined to disclose funding or ownership details, and signals collaborations with health systems such as Providence Health & Services.
Satya Nadella and Seattle Tech Leaders Join Sounders FC Ownership; Cray Gets $600M DOE Supercomputer Contract Ahead of $1.3B HPE Acquisition
Seattle tech leaders, including Microsoft CEO Satya Nadella, have joined a revamped Sounders FC ownership group. Cray is developing a $600 million exascale supercomputer for the U.S. Department of Energy and is being acquired by HPE for $1.3 billion.
Organizations
See all 4-
Truveta CEO and Co-founder 2020–2026, Chief Executive 2026, Former outgoing CEO 2026, Chief Executive Officer 2026 · past
-
Seattle Sounders Board Member 2019–2026 · past
-
Microsoft Executive Vice President 1997–2018 · past
Education
-
Duke University Bachelor of Engineering - BE, Mechanical Engineering · 1988–1991
